Skip to main content
Erschienen in: Obesity Surgery 4/2013

01.04.2013 | Economic Aspects

Gastric Bypass is a Cost-Saving Procedure: Results from a Comprehensive Markov Model

verfasst von: Gil R. Faria, John R. Preto, José Costa-Maia

Erschienen in: Obesity Surgery | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Obesity is a growing public health problem in industrialized countries and is directly and indirectly responsible for almost 10 % of all health expenditures. Bariatric surgery is the best available treatment, however, associated with important economical expenditures. So, cost-effectiveness analysis of the available surgical options is paramount.

Methods

We developed a Markov model for three different strategies: best medical management, gastric band, and gastric bypass. The Markov model was constructed to allow for the evaluation of the impact of several obesity-related comorbidities. The results were derived for a representative population of morbidly obese patients, and subgroup analyses were performed for patients without comorbidities, patients with diabetes mellitus, different age, and body mass index (BMI) groups. Cost-effectiveness analysis was performed accounting for lifetime costs and from a societal perspective.

Results

Gastric bypass is a dominant strategy, rendering a significant decrease in lifetime costs and increase in quality-adjusted life years (QALYs). Comparing with the best medical management, in the global population of patients with a BMI of >35 kg/m2, gastric bypass renders 1.9 extra QALYs and saves on average 13,244€ per patient. Younger patients, patients with a BMI between 40 and 50 kg/m2, and patients without obesity-related diseases are the ones with a bigger benefit in terms of cost effectiveness.

Conclusions

Gastric bypass surgery increases quality-adjusted survival and saves resources to health systems. As such, it can be an important process to control the ever-increasing health expenditure.
Literatur
1.
Zurück zum Zitat Salem L, Jensen CC, Flum DR. Are bariatric surgical outcomes worth their cost? A systematic review. J Am Coll Surg. 2005;200(2):270–8.PubMedCrossRef Salem L, Jensen CC, Flum DR. Are bariatric surgical outcomes worth their cost? A systematic review. J Am Coll Surg. 2005;200(2):270–8.PubMedCrossRef
2.
Zurück zum Zitat Martin LF, Tan TL, Horn JR, et al. Comparison of the costs associated with medical and surgical treatment of obesity. Surgery. 1995;118(4):599–606. discussion606–7.PubMedCrossRef Martin LF, Tan TL, Horn JR, et al. Comparison of the costs associated with medical and surgical treatment of obesity. Surgery. 1995;118(4):599–606. discussion606–7.PubMedCrossRef
3.
Zurück zum Zitat Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52.PubMedCrossRef Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52.PubMedCrossRef
4.
Zurück zum Zitat Johnson RJ, Johnson BL, Blackhurst DW, et al. Bariatric surgery is associated with a reduced risk of mortality in morbidly obese patients with a history of major cardiovascular events. Am Surg. 2012;78(6):685–92.PubMed Johnson RJ, Johnson BL, Blackhurst DW, et al. Bariatric surgery is associated with a reduced risk of mortality in morbidly obese patients with a history of major cardiovascular events. Am Surg. 2012;78(6):685–92.PubMed
5.
Zurück zum Zitat Pontiroli AE, Morabito A. Long-term prevention of mortality in morbid obesity through bariatric surgery. A systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg. 2011;253(3):484–7.PubMedCrossRef Pontiroli AE, Morabito A. Long-term prevention of mortality in morbid obesity through bariatric surgery. A systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg. 2011;253(3):484–7.PubMedCrossRef
6.
Zurück zum Zitat Ramanan B, Gupta PK, Gupta H, et al. Development and validation of a bariatric surgery mortality risk calculator. J Am Coll Surg. 2012;214(6):892–900.PubMedCrossRef Ramanan B, Gupta PK, Gupta H, et al. Development and validation of a bariatric surgery mortality risk calculator. J Am Coll Surg. 2012;214(6):892–900.PubMedCrossRef
7.
Zurück zum Zitat SAGES Guidelines Committee. SAGES guideline for clinical application of laparoscopic bariatric surgery. Surg Obes Relat Dis. 2009;5(3):387–405.CrossRef SAGES Guidelines Committee. SAGES guideline for clinical application of laparoscopic bariatric surgery. Surg Obes Relat Dis. 2009;5(3):387–405.CrossRef
8.
Zurück zum Zitat Terranova L, Busetto L, Vestri A, et al. Bariatric surgery: cost-effectiveness and budget impact. Obes Surg. 2012;22(4):646–53.PubMedCrossRef Terranova L, Busetto L, Vestri A, et al. Bariatric surgery: cost-effectiveness and budget impact. Obes Surg. 2012;22(4):646–53.PubMedCrossRef
9.
Zurück zum Zitat Mäklin S, Malmivaara A, Linna M, et al. Cost-utility of bariatric surgery for morbid obesity in Finland. Br J Surg. 2011;98(10):1422–9.PubMedCrossRef Mäklin S, Malmivaara A, Linna M, et al. Cost-utility of bariatric surgery for morbid obesity in Finland. Br J Surg. 2011;98(10):1422–9.PubMedCrossRef
10.
Zurück zum Zitat Chang S-H, Stoll CRT, Colditz GA. Cost-effectiveness of bariatric surgery: should it be universally available? Maturitas. 2011;69(3):230–8.PubMedCrossRef Chang S-H, Stoll CRT, Colditz GA. Cost-effectiveness of bariatric surgery: should it be universally available? Maturitas. 2011;69(3):230–8.PubMedCrossRef
11.
Zurück zum Zitat Welbourn R, Pournaras D. Bariatric surgery: a cost-effective intervention for morbid obesity; functional and nutritional outcomes. Proc Nutr Soc. 2010;69(4):528–35.PubMedCrossRef Welbourn R, Pournaras D. Bariatric surgery: a cost-effective intervention for morbid obesity; functional and nutritional outcomes. Proc Nutr Soc. 2010;69(4):528–35.PubMedCrossRef
12.
Zurück zum Zitat Campbell J, McGarry LA, Shikora SA, et al. Cost-effectiveness of laparoscopic gastric banding and bypass for morbid obesity. Am J Manag Care. 2010;16(7):e174–87.PubMed Campbell J, McGarry LA, Shikora SA, et al. Cost-effectiveness of laparoscopic gastric banding and bypass for morbid obesity. Am J Manag Care. 2010;16(7):e174–87.PubMed
13.
Zurück zum Zitat Anselmino M, Bammer T, Fernández Cebrián JM, et al. Cost-effectiveness and budget impact of obesity surgery in patients with type 2 diabetes in three European countries. Obes Surg. 2009;19(11):1542–9.PubMedCrossRef Anselmino M, Bammer T, Fernández Cebrián JM, et al. Cost-effectiveness and budget impact of obesity surgery in patients with type 2 diabetes in three European countries. Obes Surg. 2009;19(11):1542–9.PubMedCrossRef
14.
Zurück zum Zitat Salem L, Devlin A, Sullivan SD, et al. Cost-effectiveness analysis of laparoscopic gastric bypass, adjustable gastric banding, and nonoperative weight loss interventions. Surg Obes Relat Dis. 2008;4(1):26–32.PubMedCrossRef Salem L, Devlin A, Sullivan SD, et al. Cost-effectiveness analysis of laparoscopic gastric bypass, adjustable gastric banding, and nonoperative weight loss interventions. Surg Obes Relat Dis. 2008;4(1):26–32.PubMedCrossRef
15.
Zurück zum Zitat Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making. 1993;13(4):322–38.PubMedCrossRef Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making. 1993;13(4):322–38.PubMedCrossRef
16.
Zurück zum Zitat Hunink MGM. Decision making in health and medicine. Cambridge, UK: Cambridge University Press; 2001. Hunink MGM. Decision making in health and medicine. Cambridge, UK: Cambridge University Press; 2001.
17.
Zurück zum Zitat Brethauer SA, Chand B, Schauer PR. Risks and benefits of bariatric surgery: current evidence. Cleve Clin J Med. 2006;73(11):993–1007.PubMedCrossRef Brethauer SA, Chand B, Schauer PR. Risks and benefits of bariatric surgery: current evidence. Cleve Clin J Med. 2006;73(11):993–1007.PubMedCrossRef
18.
Zurück zum Zitat Keating CL, Dixon JB, Moodie ML, et al. Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis. Diabetes Care. 2009;32(4):567–74.PubMedCrossRef Keating CL, Dixon JB, Moodie ML, et al. Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis. Diabetes Care. 2009;32(4):567–74.PubMedCrossRef
19.
Zurück zum Zitat Wadden TA, Sternberg JA, Letizia KA, et al. Treatment of obesity by very low calorie diet, behavior therapy, and their combination: a five-year perspective. Int J Obes. 1989;2(13):39–46. Wadden TA, Sternberg JA, Letizia KA, et al. Treatment of obesity by very low calorie diet, behavior therapy, and their combination: a five-year perspective. Int J Obes. 1989;2(13):39–46.
20.
Zurück zum Zitat Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289(1):76–9.PubMedCrossRef Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289(1):76–9.PubMedCrossRef
21.
Zurück zum Zitat Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240(3):416–23. discussion423–4.PubMedCrossRef Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240(3):416–23. discussion423–4.PubMedCrossRef
22.
Zurück zum Zitat McEwen LN, Coelho RB, Baumann LM, et al. The cost, quality of life impact, and cost-utility of bariatric surgery in a managed care population. Obes Surg. 2010;20(7):919–28.PubMedCrossRef McEwen LN, Coelho RB, Baumann LM, et al. The cost, quality of life impact, and cost-utility of bariatric surgery in a managed care population. Obes Surg. 2010;20(7):919–28.PubMedCrossRef
23.
Zurück zum Zitat Arias E. United States life tables, 2006. National vital statistics reports: from the Centers for Disease Control and Prevention (2010). Arias E. United States life tables, 2006. National vital statistics reports: from the Centers for Disease Control and Prevention (2010).
24.
Zurück zum Zitat Flum DR, Dellinger EP. Impact of gastric bypass operation on survival: a population-based analysis. J Am Coll Surg. 2004;199(4):543–51.PubMedCrossRef Flum DR, Dellinger EP. Impact of gastric bypass operation on survival: a population-based analysis. J Am Coll Surg. 2004;199(4):543–51.PubMedCrossRef
25.
Zurück zum Zitat Brancati FL, Whelton PK, Randall BL, et al. Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. JAMA. 1997;278(23):2069–74.PubMedCrossRef Brancati FL, Whelton PK, Randall BL, et al. Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. JAMA. 1997;278(23):2069–74.PubMedCrossRef
28.
Zurück zum Zitat Sjöström L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56–65.PubMedCrossRef Sjöström L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56–65.PubMedCrossRef
29.
Zurück zum Zitat Davis WA, Knuiman MW, Hendrie D, et al. The obesity-driven rising costs of type 2 diabetes in Australia: projections from the fremantle diabetes study. Intern Med J. 2006;36(3):155–61.PubMedCrossRef Davis WA, Knuiman MW, Hendrie D, et al. The obesity-driven rising costs of type 2 diabetes in Australia: projections from the fremantle diabetes study. Intern Med J. 2006;36(3):155–61.PubMedCrossRef
30.
Zurück zum Zitat American Academy of Sleep Medicine. Cost justification for diagnosis and treatment of obstructive sleep apnea. Position statement of the American Academy of Sleep Medicine. Sleep. 2000;23(8):1017–8. American Academy of Sleep Medicine. Cost justification for diagnosis and treatment of obstructive sleep apnea. Position statement of the American Academy of Sleep Medicine. Sleep. 2000;23(8):1017–8.
31.
Zurück zum Zitat Gabriel SE, Crowson CS, Campion ME, et al. Direct medical costs unique to people with arthritis. J Rheumatol. 1997;24(4):719–25.PubMed Gabriel SE, Crowson CS, Campion ME, et al. Direct medical costs unique to people with arthritis. J Rheumatol. 1997;24(4):719–25.PubMed
32.
Zurück zum Zitat Potetz L. Cancer and medicare: a chartbook. Washington, DC: American Cancer Society; 2009. Potetz L. Cancer and medicare: a chartbook. Washington, DC: American Cancer Society; 2009.
33.
Zurück zum Zitat National Institutes of Health. US Renal Data System (USRDS) annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health. http://www.usrds.org/adr.htm. 2010. National Institutes of Health. US Renal Data System (USRDS) annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health. http://​www.​usrds.​org/​adr.​htm. 2010.
34.
Zurück zum Zitat Craig BM, Tseng DS. Cost-effectiveness of gastric bypass for severe obesity. Am J Med. 2002;113(6):491–8.PubMedCrossRef Craig BM, Tseng DS. Cost-effectiveness of gastric bypass for severe obesity. Am J Med. 2002;113(6):491–8.PubMedCrossRef
35.
Zurück zum Zitat De Smedt D, De Cocker K, Annemans L, et al. A cost-effectiveness study of the community-based intervention ’10,000 steps Ghent’. Public Health Nutr. 2012;15(3):442–51.PubMedCrossRef De Smedt D, De Cocker K, Annemans L, et al. A cost-effectiveness study of the community-based intervention ’10,000 steps Ghent’. Public Health Nutr. 2012;15(3):442–51.PubMedCrossRef
36.
Zurück zum Zitat Pollock RF, Valentine WJ, Pilgaard T, et al. The cost effectiveness of rapid-acting insulin aspart compared with human insulin in type 2 diabetes patients: an analysis from the Japanese third-party payer perspective. J Med Econ. 2011;14(1):36–46.PubMedCrossRef Pollock RF, Valentine WJ, Pilgaard T, et al. The cost effectiveness of rapid-acting insulin aspart compared with human insulin in type 2 diabetes patients: an analysis from the Japanese third-party payer perspective. J Med Econ. 2011;14(1):36–46.PubMedCrossRef
37.
Zurück zum Zitat Padwal RS, Majumdar SR, Klarenbach S, et al. The Alberta population-based prospective evaluation of the quality of life outcomes and economic impact of bariatric surgery (APPLES) study: background, design and rationale. BMC Health Serv Res. 2010;10:284.PubMedCrossRef Padwal RS, Majumdar SR, Klarenbach S, et al. The Alberta population-based prospective evaluation of the quality of life outcomes and economic impact of bariatric surgery (APPLES) study: background, design and rationale. BMC Health Serv Res. 2010;10:284.PubMedCrossRef
38.
Zurück zum Zitat Ackroyd R, Mouiel J, Chevallier J-M, et al. Cost-effectiveness and budget impact of obesity surgery in patients with type-2 diabetes in three European countries. Obes Surg. 2006;16(11):1488–503.PubMedCrossRef Ackroyd R, Mouiel J, Chevallier J-M, et al. Cost-effectiveness and budget impact of obesity surgery in patients with type-2 diabetes in three European countries. Obes Surg. 2006;16(11):1488–503.PubMedCrossRef
39.
Zurück zum Zitat Chevallier J-M, Daoud F, Szwarcensztein K, et al. Medicoeconomic evaluation of the treatment of morbid obesity by Swedish adjustable gastric banding (SAGB). Ann Chir. 2006;131(1):12–21.PubMedCrossRef Chevallier J-M, Daoud F, Szwarcensztein K, et al. Medicoeconomic evaluation of the treatment of morbid obesity by Swedish adjustable gastric banding (SAGB). Ann Chir. 2006;131(1):12–21.PubMedCrossRef
40.
Zurück zum Zitat Reis CEG, Alvarez-Leite JI, Bressan J, et al. Role of bariatric-metabolic surgery in the treatment of obese type 2 diabetes with body mass index. Diabetes Technol Ther. 2012;14(4):365–72.PubMedCrossRef Reis CEG, Alvarez-Leite JI, Bressan J, et al. Role of bariatric-metabolic surgery in the treatment of obese type 2 diabetes with body mass index. Diabetes Technol Ther. 2012;14(4):365–72.PubMedCrossRef
41.
Zurück zum Zitat Deitel M. Bariatric surgery is a cost-saving for the healthcare system. Obes Surg. 2005;15(3):301–3.PubMedCrossRef Deitel M. Bariatric surgery is a cost-saving for the healthcare system. Obes Surg. 2005;15(3):301–3.PubMedCrossRef
Metadaten
Titel
Gastric Bypass is a Cost-Saving Procedure: Results from a Comprehensive Markov Model
verfasst von
Gil R. Faria
John R. Preto
José Costa-Maia
Publikationsdatum
01.04.2013
Verlag
Springer-Verlag
Erschienen in
Obesity Surgery / Ausgabe 4/2013
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-012-0816-8

Weitere Artikel der Ausgabe 4/2013

Obesity Surgery 4/2013 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.